½ÃÀ庸°í¼­
»óǰÄÚµå
1675389

EDC ½Ã½ºÅÛ(ÀüÀÚ µ¥ÀÌÅÍ Ä¸Ã³ ½Ã½ºÅÛ) ½ÃÀå : Á¦°ø ¸ðµåº°, ÄÄÆ÷³ÍÆ®º°, °³¹ß ´Ü°èº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)

Electronic Data Capture Systems Market Report by Delivery Mode, Component, Development Phase, End User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ EDC ½Ã½ºÅÛ(ÀüÀÚ µ¥ÀÌÅÍ Ä¸Ã³ ½Ã½ºÅÛ) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 14¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 33¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³â¿¡ 9.7%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀÇ ±Þ¼ÓÇÑ µðÁöÅÐÈ­, Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀÇ Ã¤Åà Áõ°¡, ¸ð¹ÙÀÏ EDCÀÇ µµÀÔÀº ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù.

EDC ½Ã½ºÅÛÀº ÀÓ»ó½ÃÇè µ¥ÀÌÅ͸¦ ÀüÀÚÀû ÇüÅ·Π¼öÁýÇÏ°í °ü¸®Çϱâ À§ÇØ ¼³°èµÈ ¼ÒÇÁÆ®¿þ¾î Åø·Î, ȯÀÚ ¼Ó¼º, º´·Â, ºÎÀÛ¿ë, °Ë»ç °á°ú, ÀÓ»ó °á°ú Æò°¡, ÀüÀÚµ¿ÀǼ­(eConsent), ÀÓ»ó½ÃÇè ½Ç½Ã±â°ü Á¤º¸ µî ´Ù¾çÇÑ µ¥ÀÌÅ͸¦ ¼öÁýÇÕ´Ï´Ù. EDC ½Ã½ºÅÛÀº ±ÔÁ¦ ´ç±¹, ÀÓ»ó½ÃÇè ÀÇ·ÚÀÚ, ÀÓ»ó½ÃÇè ¼öʱâ°ü(CRO), ÀÓ»ó½ÃÇè Âü¿©ÀÚ ¹× µ¥ÀÌÅÍ °ü¸®ÀÚ°¡ ³Î¸® »ç¿ëÇϰí ÀÖÀ¸¸ç, µ¥ÀÌÅÍ ¼öÁý °£¼ÒÈ­, µ¥ÀÌÅÍ Ç°Áú Çâ»ó, ÀÎÀû ¿À·ù ÃÖ¼ÒÈ­, ±â¹Ð Á¤º¸ º¸È£, µ¥ÀÌÅÍ À¯Ãâ ¹× Áߺ¹ À§Çè °¨¼Ò¿¡ µµ¿òÀÌ µË´Ï´Ù. EDC ½Ã½ºÅÛÀº ¶ÇÇÑ ÀÓ»ó½ÃÇèÀÇ È¿À²¼ºÀ» ³ôÀ̰í, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ±â´ÉÀ» Á¦°øÇϸç, ÀÇ»ç°áÁ¤À» Áö¿øÇϰí, µ¥ÀÌÅÍÀÇ Á¤È®¼º, ½Å·Ú¼º, Àϰü¼ºÀ» º¸ÀåÇÕ´Ï´Ù.

EDC ½Ã½ºÅÛ ½ÃÀå µ¿Çâ :

EDC ½Ã½ºÅÛÀº µ¥ÀÌÅÍ ¼öÁý, ÀúÀå, ¸ð´ÏÅ͸µ, ºÐ¼® µî ´Ù¾çÇÑ ÀÓ»ó½ÃÇè ¾÷¹«ÀÇ ÀÚµ¿È­¿¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ÇÁ·Î¼¼½º °¡¼ÓÈ­, Åõ¸í¼º Çâ»ó, ¿À·ù ¹æÁö, Àü¹ÝÀûÀÎ È¿À²¼º Çâ»ó, µ¥ÀÌÅÍ ¼öÁý, ÀúÀå, ¸ð´ÏÅ͸µ, ºÐ¼® µî ´Ù¾çÇÑ ÀÓ»ó½ÃÇè ¾÷¹«ÀÇ ÀÚµ¿È­¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀÎ È¿À²È­¸¦ ½ÇÇöÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ç´¢º´, °íÇ÷¾Ð, ¾ËÃ÷ÇÏÀ̸Ӻ´, ´Ù¹ß¼º °æÈ­Áõ, ½ÉÇ÷°ü Áúȯ(CVDs)°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇÑ »õ·Î¿î Ä¡·á¹ý ¹× Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¿ë È¿À²ÀûÀ̰í, »ç¿ëÀÚ Ä£È­ÀûÀ̸ç, È®Àå °¡´ÉÇϰí, ¾ÈÀüÇϸç, ½Ç½Ã°£À¸·Î µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö Àִ Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ź·ÂÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½º¸¶Æ®Æù ¹× ÅÂºí¸´À» ÀÌ¿ëÇÑ ¸ð¹ÙÀÏ EDCÀÇ µµÀÔÀº ȯÀÚ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ´Â Æí¸®ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¹æ¹ýÀ¸·Î Âü¿©µµ¸¦ ³ôÀ̰í, ÄÄÇöóÀ̾𽺸¦ °­È­Çϸç, ¿À·ùÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, µ¥ÀÌÅÍ ºÐ¼®À» °³¼±ÇÏ°í ½Å¼ÓÇÑ ÀÇ»ç°áÁ¤À» °¡´ÉÇÏ°Ô ÇÏ¸ç ÆÐÅÏ, Ãß¼¼, ÀÌ»ó ¡Èĸ¦ ½Äº°Çϱâ À§ÇÑ ¸Ó½Å·¯´×(ML)°ú ÀΰøÁö´É(AI)ÀÇ ÅëÇÕÀº ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÓ»ó½ÃÇè µ¥ÀÌÅÍÀÇ ¾ÈÀü°ú ¹«°á¼º¿¡ ´ëÇÑ ¾ö°ÝÇÑ Á¤ºÎ ±ÔÁ¦°¡ ½ÃÇàµÇ¸é¼­ ±ÔÁ¦ ´ç±¹ÀÇ ÄÄÇöóÀ̾𽺠°­È­¸¦ Áö¿øÇÏ´Â EDC¿Í °°Àº °í±Þ µ¥ÀÌÅÍ °ü¸® ¹× º¸°í ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ °³ÀÎ ¸ÂÃãÇü ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±¤¹üÀ§ÇÑ R&D Ȱµ¿, ȯÀÚ Á᫐ ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ °ü½É Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • ¼¼°è EDC ½Ã½ºÅÛ ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ÃßÀÌÇØ ¿ÔÀ¸¸ç, ÇâÈÄ ¼ö³â°£ ¾î¶»°Ô ÃßÀÌÇϴ°¡?
  • ¼¼°è EDC ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ´Â ¹«¾ùÀΰ¡?
  • °¢ ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ°¡ ¼¼°è EDC ½Ã½ºÅÛ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº?
  • EDC ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ ±¹°¡´Â?
  • Á¦°ø ¸ðµå¿¡ µû¸¥ ½ÃÀå ºÐ¼®Àº?
  • EDC ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ Á¦°ø ¸ðµå´Â?
  • ÄÄÆ÷³ÍÆ®º° ½ÃÀå ºÐ¼®Àº?
  • EDC ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ ±¸¼º ¿ä¼Ò´Â ¹«¾ùÀΰ¡?
  • °³¹ß ´Ü°è¿¡ µû¸¥ ½ÃÀå ºÐ¼®Àº?
  • EDC ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ °³¹ß ´Ü°è´Â?
  • ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ºÐ¼®Àº?
  • EDC ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ ÃÖÁ¾»ç¿ëÀÚ´Â?
  • ¼¼°è EDC ½Ã½ºÅÛ ½ÃÀåÀÇ °æÀï ±¸µµ´Â?
  • ¼¼°èÀÇ EDC ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ ¾îÇÁ·ÎÄ¡
    • Åé´Ù¿î ¾îÇÁ·ÎÄ¡
  • Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ EDC ½Ã½ºÅÛ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦°ø ¸ðµåº°

  • ¿ÂÇÁ·¹¹Ì½º
  • À¥¡¤Å¬¶ó¿ìµå ±â¹Ý

Á¦7Àå ½ÃÀå ³»¿ª : ÄÄÆ÷³ÍÆ®º°

  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦8Àå ½ÃÀå ³»¿ª : °³¹ß ´Ü°èº°

  • ´Ü°è I
  • ´Ü°è II
  • ´Ü°è III
  • ´Ü°è IV

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø/ÀÇ·á Á¦°øÀÚ
  • CRO
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ÀÇ·á±â±â ±â¾÷
  • ±âŸ

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå ³»¿ª : ±¹°¡º°

Á¦11Àå ÃËÁø¿äÀΡ¤¾ïÁ¦¿äÀΡ¤±âȸ

  • °³¿ä
  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀïÀÇ Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ÀÇ °³¿ä
    • Anju Software Inc.
    • Calyx
    • Clario
    • Datatrak Int
    • Medidata Solutions Inc.
    • OpenClinica, LLC
    • Oracle Corporation
    • Veeva Systems
KSA 25.04.07

The global electronic data capture (EDC) systems market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. The rapid digitalization of clinical trials, the rising adoption of the cloud-based system, and the introduction of mobile-EDC represent some of the key factors driving the market.

Electronic data capture (EDC) systems refer to software tools designed to collect and manage clinical trial data in electronic format. They capture a wide variety of data, including patient demographics, medical history, adverse events, laboratory results, clinical outcome assessments, electronic informed consent (eConsent), and study site information. EDC systems are widely used by regulatory agencies, clinical trial sponsors, contract research organizations (CROs), trial participants, and data managers. They help streamline data collection, improve data quality, minimize human errors, protect sensitive information, and reduce the risk of data loss and duplications. EDC systems also enhance the efficiency of the clinical trial, provide real-time monitoring capabilities, assist in decision-making, and ensure data accuracy, reliability, and consistency.

Electronic Data Capture (EDC) Systems Market Trends:

The rapid digitalization of clinical trials across the globe is one of the primary factors propelling the market growth. EDC systems are widely used to automate various clinical trial operations, such as data collection, storage, monitoring, and analysis, which, in turn, accelerate the process, provide transparency, prevent errors, and improve overall efficiency. In addition to this, the growing demand for new treatments and therapeutics due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, Alzheimer's disease, multiple sclerosis, and cardiovascular diseases (CVDs), are acting as another growth-inducing factor. Furthermore, the rising adoption of the cloud-based system, which is cost-effective, user-friendly, scalable, highly secure, and offers real-time access to data, is providing an impetus to the market growth. Additionally, the introduction of mobile-EDC, which utilize smartphones or tablets as a convenient and cost-effective way to collect patients' data, thus improving engagement, increasing compliance, and reducing the risk of errors, is favoring the market growth. Apart from this, the integration of machine learning (ML) and artificial intelligence (AI) to improve data analysis, enable faster decision-making, and identify patterns, trends, and anomalies is positively influencing the market growth. Moreover, the implementation of stringent government regulations regarding the safety and integrity of clinical trial data is facilitating the demand for advanced data management and reporting systems, such as EDC, which aids in ensuring greater compliance with the authorities. Other factors, including increasing demand for personalized medicines, extensive research and development (R&D) activities, and the growing focus on patient-centric clinical trials, are anticipated to drive the market growth.

Key Market Segmentation:

Delivery Mode Insights:

  • On-premise
  • Web & Cloud-based

Component Insights:

  • Software
  • Services

Development Phase Insights:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

End User Insights:

  • Hospitals/Healthcare Providers
  • CROs
  • Pharmaceutical and Biotechnology Firms
  • Medical Device Firms
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for electronic data capture (EDC) systems. Some of the factors driving the North America electronic data capture (EDC) systems market included the rising prevalence of chronic diseases, increasing government initiatives, and rapid technological advancements.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global electronic data capture (EDC) systems market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anju Software Inc., Calyx, Clario, Datatrak Int, Medidata Solutions Inc., OpenClinica, LLC, Oracle Corporation, Veeva Systems, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global electronic data capture (EDC) systems market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global electronic data capture (EDC) systems market?
  • What is the impact of each driver, restraint, and opportunity on the global electronic data capture (EDC) systems market?
  • What are the key regional markets?
  • Which countries represent the most attractive electronic data capture (EDC) systems market?
  • What is the breakup of the market based on the delivery mode?
  • Which is the most attractive delivery mode in the electronic data capture (EDC) systems market?
  • What is the breakup of the market based on the component?
  • Which is the most attractive component in the electronic data capture (EDC) systems market?
  • What is the breakup of the market based on development phase?
  • Which is the most attractive development phase in the electronic data capture (EDC) systems market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the electronic data capture (EDC) systems market?
  • What is the competitive structure of the global electronic data capture (EDC) systems market?
  • Who are the key players/companies in the global electronic data capture (EDC) systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Electronic Data Capture (EDC) Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Delivery Mode

  • 6.1 On-premise
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Web & Cloud-based
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Component

  • 7.1 Software
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Services
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Development Phase

  • 8.1 Phase I
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Phase II
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Phase III
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Phase IV
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals/Healthcare Providers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 CROs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Firms
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Medical Device Firms
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Anju Software Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Calyx
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Clario
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Datatrak Int
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Medidata Solutions Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 OpenClinica, LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Oracle Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Veeva Systems
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦